Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2021-05-27 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
关于调整2018年股票期权激励计划股票期权行权价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the adjustment of the exercise price of stock options under its 2018 stock option incentive plan. It details the board and supervisory meetings, approvals, legal opinions, and the rationale for the adjustment. The document does not contain financial statements or comprehensive financial performance data but focuses on a specific corporate action related to stock option plans. This type of announcement fits best under Capital/Financing Update (CAP) as it relates to changes in the company's capital structure through stock option exercise price adjustments. The document length is about 5140 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the classification is CAP with high confidence.
2021-05-27 Chinese
关于公司董事长所持公司股份变动的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding a change in shareholding by the company's chairman, specifically about the transfer of shares held by the chairman to an entity he controls. It details the number of shares transferred, the price, and compliance with relevant regulations. There is no financial report, earnings data, or management discussion. The document is a disclosure of a director's personal share transaction (insider dealing). Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on shareholding changes by a director, confirming this classification.
2021-05-17 Chinese
关于参加2021年云南辖区上市公司投资者网上集体接待日活动的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the company's participation in an online investor collective reception day event organized by a regional stock association. It mentions interaction with investors regarding the 2020 annual report, governance, strategy, operations, financing plans, equity incentives, and sustainability. The document is short (598 characters) and serves as a notice of an upcoming investor event rather than the event materials or a detailed report. It does not contain financial statements or detailed financial data. Therefore, it is best classified as an Investor Presentation (IP) since it relates to a presentation or communication aimed at investors about company performance and plans.
2021-05-12 Chinese
2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an 'Annual Equity Distribution Implementation Announcement' for the year 2020 by Yunnan Watson Biotechnology Co., Ltd. It details the dividend distribution plan approved at the 2020 Annual General Meeting held on April 16, 2021, including the dividend amount, record date, ex-dividend date, and related procedural information. The document is an announcement of the implementation of the dividend distribution, not the dividend notice itself nor a full financial report. It is relatively short (1908 characters) and focuses on the dividend distribution details following shareholder approval. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and details for shareholders.
2021-05-12 Chinese
关于子公司收到境外发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about its subsidiary receiving a foreign invention patent certificate. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, and no meeting or voting information. The document is an official announcement about intellectual property rights, not a financial report or management information. It is brief (580 characters) and serves as a regulatory announcement about a patent. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2021-05-07 Chinese
关于股东股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the release of pledged shares by a shareholder, detailing the number of shares released from pledge and related information. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about shareholder share pledge status changes, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2021-05-07 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.